- Open Access
Erratum to: Clusterin confers gemcitabine resistance in pancreatic cancer
World Journal of Surgical Oncology volume 11, Article number: 149 (2013)
- The original article was published in World Journal of Surgical Oncology 2011 9:59
After the publication of this work , we noticed that we had incorrectly used the term ‘OGX-011’. All instances of OGX-011 in the manuscript should be changed to ‘ASO-CLU’.
We apologise to the readers and OncoGenex Technologies for this oversight and any negative effects that may have resulted from it.
Chen : Clusterin confers gmcitabine resistance in pancreatic cancer. World J Surg Oncol. 2011, 9: 59-10.1186/1477-7819-9-59.
The online version of the original article can be found at 10.1186/1477-7819-9-59
Qingfeng Chen, Zhengkun Wang, Kejun Zhang contributed equally to this work.
About this article
Cite this article
Chen, Q., Wang, Z., Zhang, K. et al. Erratum to: Clusterin confers gemcitabine resistance in pancreatic cancer. World J Surg Onc 11, 149 (2013). https://doi.org/10.1186/1477-7819-11-149